Medgend Icon







discontinued


Axiron FDA Approved Drugs

ANDRODERM [TestosteroneC19H28O2]
RX
-
2mg/24hr (transdermal film, extended release)
4mg/24hr (transdermal film, extended release)
Allergan Sales LlcOct 20, 2011
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ANDROGEL [TestosteroneC19H28O2]
RX
-
1.62% (20.25mg/1.25gm actuation) (transdermal gel, metered)
1.62% (20.25mg/1.25gm packet) (transdermal gel)
1.62% (40.5mg/2.5gm packet) (transdermal gel)
12.5mg/1.25gm actuation (transdermal gel, metered)
25mg/2.5gm packet (transdermal gel)
50mg/5gm packet (transdermal gel)
AbbvieApr 29, 2011
  • Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

AXIRON [TestosteroneC19H28O2]
RX
-
30mg/1.5ml actuation (transdermal solution, metered)
Eli Lilly And CoNov 23, 2010
  • A method of increasing the testosterone blood level of a person in need thereof.
  • A method of increasing the testosterone blood level of an adult male subject in need thereof.
  • A method of transdermal administration of a physiologically active agent to a subject..
  • A method of transdermally delivering testosterone.
  • Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FORTESTA [TestosteroneC19H28O2]
RX
-
10mg/0.5gm actuation (transdermal gel, metered)
Endo PharmsDec 29, 2010
  • Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NATESTO [TestosteroneC19H28O2]
RX
-
5.5mg/0.122gm actuation (nasal gel, metered)
Aytu Bioscience IncMay 28, 2014
  • A method of testosterone replacement therapy comprising the step of nasally administering to a patient in need of such treatment an effective amount of testosterone gel formulation..
  • Nasal administration of a testosterone gel to a patient to treat the patient for a condition associated with a deficiency or absence of endogenous testosterone.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

STRIANT [TestosteroneC19H28O2]
RX
-
30mg (buccal tablet, extended release)
Auxilium Pharms LlcJun 19, 2003
  • Method of delivering an active ingredient using a progressive hydration bioadhesive.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TESTIM [TestosteroneC19H28O2]
RX
-
50mg/5gm packet (transdermal gel)
Auxilium Pharms LlcOct 31, 2002
  • Method for administration of testosterone.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TESTOPEL [TestosteroneC19H28O2]
RX
-
75mg (implantation pellet)
Auxilium Pharms IncApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TESTOSTERONE [TestosteroneC19H28O2]
RX
-
1.62% (20.25mg/1.25gm actuation) (transdermal gel, metered)
1.62% (20.25mg/1.25gm packet) (transdermal gel)
1.62% (40.5mg/2.5gm packet) (transdermal gel)
10mg/0.5gm actuation (transdermal gel, metered)
12.5mg/1.25gm actuation (transdermal gel, metered)
25mg/2.5gm packet (transdermal gel)
30mg/1.5ml actuation (transdermal solution, metered)
50mg/5gm packet (transdermal gel)
Perrigo IsraelAug 4, 2015
Perrigo Uk FincoJul 12, 2017
Actavis Labs Ut IncAug 5, 2015
Ani Pharms IncFeb 14, 2012
Par PharmMay 23, 2007
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VOGELXO [TestosteroneC19H28O2]
RX
-
12.5mg/1.25gm actuation (transdermal gel, metered)
50mg/5gm packet (transdermal gel)
Upsher-smith LabsJun 4, 2014
  • Method for transdermal delivery of testosterone.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.